CTC STORY
CTC STORY
Liquid Biopsy
Application
TECHNOLOGY
TECHNOLOGY
CTC Isolation
Biomarker Evaluation
CTC Analysis
CTC Culture
Liquid Biopsy Platform
Single Cell RNA Sequencing
SERVICE & PRODUCT
SERVICE & PRODUCT
Cancer Drug Development
Cancer Drug Monitoring
Companion Diagnostics
Clinical Research
Pet Cancer Diagnosing
CLIA
Preclinical Xenograft Model
Liquid Biopsy Equipment
IR/PR
IR/PR
News
Publication & Presentation
ABOUT US
ABOUT US
Company Overview
Vision
History
Location
Contact
ENG
KOR
SERVICE & PRODUCT
SERVICE & PRODUCT
CTC STORY
TECHNOLOGY
SERVICE & PRODUCT
IR/PR
ABOUT US
Preclinical Xenograft Model
Cancer Drug Development
Cancer Drug Monitoring
Companion Diagnostics
Clinical Research
Pet Cancer Diagnosing
CLIA
Preclinical Xenograft Model
Liquid Biopsy Equipment
Preclinical Xenograft Model
>
SERVICE & PRODUCT
>
Preclinical Xenograft Model
The liquid biopsy platform is applied to the PDX model to detect CTCs from resistant patients and to efficiently evaluate new drug efficacy.
Starting from domestic contracts, we look forward to expanding business with many domestic and overseas pharmaceutical companies.
Significance of PDX Development and Effects
- Development of animal models for the efficacy test of anticancer drugs in vivo.
- Evaluation /validation of efficacy of a drug prior to clinical trials.
- Cut hours and costs for the drug development by minimizing unnecessary clinical trials using PDX mouse model.
PDX model
Anticancer Drug Evaluation Using PDX Mouse
Repeated cancer cell sampling through CTC-based liquid biopsy Accurate and Effective Anticancer Drug Analysis